Big Tech Stocks Today: Magnificent Seven Mixed After Jobs Data, With Tesla and Meta Outperforming (US Market, Dec. 16, 2025)

Big Tech Stocks Today: Magnificent Seven Mixed After Jobs Data, With Tesla and Meta Outperforming (US Market, Dec. 16, 2025)

Big Tech stocks were mixed in early afternoon trading on Tuesday, December 16, 2025, as investors balanced a fresh U.S. jobs report, shifting expectations for 2026 interest-rate cuts, and the ongoing debate over whether AI infrastructure spending is a durable growth engine—or the next valuation trap. Shortly before 1:45 p.m. ET (prices below reflect trades around 1:35–1:40 p.m. ET), the broader market was modestly lower while leadership inside Big Tech split into two camps: Tesla and Meta higher, Alphabet leading declines, and Nvidia hovering near flat-to-up as the AI narrative evolved again. Big Tech stocks at a glance (early afternoon, ET) Here’s where the core “Magnificent Seven”
Oceaneering International (OII) Stock News Today: Why Shares Fell on Dec. 16, 2025 — Forecasts, Analyst Targets, and What Investors Are Watching

Oceaneering International (OII) Stock News Today: Why Shares Fell on Dec. 16, 2025 — Forecasts, Analyst Targets, and What Investors Are Watching

Oceaneering International, Inc. (NYSE: OII) stock slid sharply on Tuesday, December 16, 2025, a move that put the offshore-technology and subsea robotics specialist back in the spotlight after a choppy stretch in recent sessions. In afternoon trading, OII was around $24.21, down about 6.4% on the day, after opening near $25.57 and trading between $23.89 and $25.66. StockAnalysis The drop comes as investors weigh a mix of factors: a notable one-day pullback, a generally cautious “Hold” stance from many Wall Street analysts, and a company outlook that points to 2026 growth led by its defense-focused ADTech segment—with seasonal softness expected
16 December 2025
Semiconductor Stocks Today (Dec. 16, 2025): Nvidia, Broadcom, Micron and Chip Equipment Makers Drive Midday Moves on Wall Street

Semiconductor Stocks Today (Dec. 16, 2025): Nvidia, Broadcom, Micron and Chip Equipment Makers Drive Midday Moves on Wall Street

NEW YORK — Tuesday, Dec. 16, 2025 (around 1:45 p.m. ET) — U.S.-listed semiconductor stocks are trading mixed midday as investors juggle three cross-currents at once: a shutdown-delayed jobs report that’s reshaping rate expectations, fresh forecasts for a multi-year surge in chipmaking equipment spend, and a renewed debate over how profitable the AI buildout will be for every layer of the chip supply chain. The result is a market that’s still treating “AI semiconductors” as the structural growth story—but pricing the winners and losers far more aggressively than it did earlier in 2025. Semiconductor stocks today: a quick midday snapshot As
Nebius Group (NBIS) Stock Slides as AI “Neocloud” Volatility Returns: News, Forecasts and Analysis for Dec. 16, 2025

Nebius Group (NBIS) Stock Slides as AI “Neocloud” Volatility Returns: News, Forecasts and Analysis for Dec. 16, 2025

Nebius Group N.V. (NASDAQ: NBIS) shares were lower on Tuesday, December 16, 2025, extending a recent pullback that has split Wall Street into two camps: investors who see Nebius as a scarce, high-demand “AI infrastructure” winner, and skeptics who argue the stock’s fundamentals can’t yet justify the volatility and valuation. As of the latest trade Tuesday, NBIS was around $78.54, down about 3.2% on the day, with an intraday range of roughly $76.95 to $81.88 and volume near 9.5 million shares. That decline follows a sharp drop in the prior session: MarketBeat reported NBIS fell 7.5% on Monday to about
EV Stocks Today: Tesla Near Record High on Driverless Robotaxi Tests as Ford’s $19.5B EV Reset and a Charging Lawsuit Jolt the Sector (Dec. 16, 2025)

EV Stocks Today: Tesla Near Record High on Driverless Robotaxi Tests as Ford’s $19.5B EV Reset and a Charging Lawsuit Jolt the Sector (Dec. 16, 2025)

Electric vehicle (EV) stocks are trading on a split screen Tuesday, December 16, 2025: Tesla is climbing toward record territory on fresh robotaxi momentum, while much of the broader EV ecosystem—from early-stage automakers to charging names—faces a tougher tape as investors digest a major Ford strategy pivot, policy uncertainty around charging buildouts, and rate-sensitive market moves following the delayed U.S. jobs report. Below is what matters most for EV stocks today in the U.S. stock market, as of ~1:45 PM ET (intraday), and what investors are watching next. EV stocks snapshot (U.S.-listed) around 1:45 PM ET Moves are intraday vs. the prior close and change quickly. Tesla
SoFi Stock (SOFI) News Today: $1.5B Share Offering Fallout, Analyst Targets, and 2026 Forecasts (Dec. 16, 2025)

SoFi Stock (SOFI) News Today: $1.5B Share Offering Fallout, Analyst Targets, and 2026 Forecasts (Dec. 16, 2025)

SoFi Technologies, Inc. (NASDAQ: SOFI) is back in focus on Tuesday, December 16, 2025, as investors weigh a December equity raise, fresh product rollouts, and a growing stack of mixed analyst calls heading into 2026. Shares traded around $26.16 in the latest data Tuesday, up about 1.3% from the prior close, after ranging between roughly $25.42 and $26.74 during the session. The stock remains about 20% below its $32.73 all-time high set on November 12, 2025, underscoring how quickly sentiment can swing in high-beta fintech names. TradingView Below is a detailed rundown of the key news, forecasts, and analyses circulating
16 December 2025
Home Depot Stock (NYSE: HD) Update on Dec. 16, 2025: Analyst Price Targets, 2026 Outlook, and the Headlines Moving Shares

Home Depot Stock (NYSE: HD) Update on Dec. 16, 2025: Analyst Price Targets, 2026 Outlook, and the Headlines Moving Shares

Home Depot, Inc. (The) stock (NYSE: HD) is back in focus on Tuesday, December 16, 2025, as investors weigh a fresh analyst price-target move, the company’s newly set preliminary fiscal 2026 outlook, and a cybersecurity headline that has kept risk watchers attentive. At midday, HD was trading in the mid-$350s, after a volatile stretch that began with management’s Investor and Analyst Conference last week and continued through a wave of analyst revisions. StockAnalysis+1 Below is a comprehensive roundup of today’s key HD stock news, current forecasts, and the most relevant analysis shaping sentiment on Dec. 16. Home Depot stock price
16 December 2025
Coca-Cola Stock (KO) News and Forecasts for Dec. 16, 2025: Analyst Targets, Dividend Outlook, and Key Catalysts

Coca-Cola Stock (KO) News and Forecasts for Dec. 16, 2025: Analyst Targets, Dividend Outlook, and Key Catalysts

Coca-Cola stock (NYSE: KO) is trading near $70.84 on Tuesday, Dec. 16, 2025, down modestly on the session (about -0.18% as of the early afternoon timestamp shown by StockAnalysis). The day’s range has been tight—roughly $71.30 at the high and $70.54 at the low—reflecting the defensive, lower-volatility profile investors typically associate with the beverage giant. StockAnalysis While there’s no single “earnings-style” headline hitting today, KO is in the middle of several market narratives that matter for 2026 positioning: leadership transitions across consumer staples, continued focus on profitability via bottler refranchising, and the ever-present debate over whether Coca-Cola’s premium valuation is
16 December 2025
Globalstar (GSAT) Stock News on Dec. 16, 2025: Deutsche Bank Starts Coverage, Skydio Drone Trial, and Updated Analyst Forecasts

Globalstar (GSAT) Stock News on Dec. 16, 2025: Deutsche Bank Starts Coverage, Skydio Drone Trial, and Updated Analyst Forecasts

Globalstar, Inc. stock (NASDAQ: GSAT) traded sharply lower on Tuesday, December 16, 2025, despite fresh operational news highlighting its licensed spectrum and private 5G ambitions. Shares were down about 8.5% at $63.20 in the latest trading update (after opening near $67.75 and swinging between $69.05 and $62.84), underscoring how sensitive GSAT has become to valuation and “what’s next” narratives after a huge run in 2025. Two developments dominated today’s headlines: Together, those updates paint a very 2025 kind of investing picture: the technology story keeps getting stronger, while the “price you pay for the story” is where the fight breaks
16 December 2025
Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics Incorporated (NASDAQ: CORT) ended Tuesday, December 16, 2025, sharply lower after a strong 2025 run that had pushed expectations—and valuation—into the spotlight. Shares closed at $79.44, down $7.86 (about 9%) from the prior close, after trading as low as $78.84 on the day. The day’s narrative around Corcept Therapeutics stock wasn’t driven by a single blockbuster headline like an FDA decision or a clinical-trial halt. Instead, it was a classic “high-expectations” session: fresh sell-side coverage, valuation-focused commentary, and investors recalibrating risk ahead of a major FDA catalyst for relacorilant later this month. Below is a complete roundup of
PBF Energy Stock Slides on Refinery Headlines: Today’s News, Analyst Forecasts, and Outlook for NYSE:PBF (December 16, 2025)

PBF Energy Stock Slides on Refinery Headlines: Today’s News, Analyst Forecasts, and Outlook for NYSE:PBF (December 16, 2025)

PBF Energy Inc. stock (NYSE:PBF) is having a rough session on Tuesday, December 16, 2025, with shares trading around $27.13, down roughly 9% on the day after opening near $29.28 and touching an intraday range of about $26.85 to $29.37. Investing.com That kind of drop isn’t usually about one single headline. For refiners like PBF, the market often reacts to a messy cocktail of factors—operational incidents, regulatory scrutiny, and the broader crude/product price backdrop. Today’s flow of reporting fits that pattern, especially with fresh attention on PBF-linked refinery developments and a generally softer tone in energy tied to falling oil
16 December 2025
Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Inc. (NASDAQ: AMGN) is in focus on December 16, 2025, as investors weigh a fresh dividend raise, recent regulatory momentum, and a pipeline narrative that stretches from cardiovascular outcomes to the high-stakes obesity race. As of Dec. 16, 2025 (18:00 UTC), Amgen shares traded around $324.36, slightly lower on the day, with an intraday range roughly between $323.05 and $326.03. While price action is calm, the story around AMGN is busy—especially for long-term investors looking for a blend of income, defensiveness, and late-stage catalysts. What’s driving Amgen stock on Dec. 16: dividends back in the spotlight A key theme
16 December 2025
Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina Corporation (NASDAQ: SANM) stock fell sharply in Tuesday trading, even as the company unveiled two growth-oriented moves aimed at the U.S. power-grid equipment market: a new, state-of-the-art energy-focused factory planned for Houston and a transformer co-design agreement with Croatia’s Končar Group. At last check on Dec. 16, SANM shares were down about 8.85% at $144.17, after swinging between an intraday high of $159.98 and a low of $144.17. The market’s reaction highlights a familiar tension in “build for the future” announcements: investors may like the destination, but they immediately start interrogating the travel budget—capital spending, cash flow timing, and
16 December 2025
AbbVie Stock (ABBV) News, Forecasts and Analysis for Dec. 16, 2025: BofA Trims Target as Pipeline Catalysts Stay in Focus

AbbVie Stock (ABBV) News, Forecasts and Analysis for Dec. 16, 2025: BofA Trims Target as Pipeline Catalysts Stay in Focus

AbbVie Inc. (NYSE: ABBV) is trading lower on Tuesday, December 16, 2025, after a strong run earlier in the quarter and a Monday close that kept the stock near the upper end of its 52‑week range. As of 17:54 UTC on Dec. 16, ABBV was at $222.44, down $5.01 (-2.20%) on the session, with an intraday range of $222.44 to $228.00. Today’s AbbVie coverage is being driven less by a single blockbuster headline and more by the familiar mix of Wall Street recalibration and pipeline expectations: Bank of America trimmed its price target, while fresh pipeline-focused analysis reiterated the thesis
Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan, Inc. (NASDAQ: NAVN) stock was one of the market’s sharpest decliners on Tuesday, December 16, 2025, sliding roughly high-teens after the company’s first post-IPO earnings report landed with a thud—and after investors digested news that the company’s CFO plans to step down early next month. Barron’s+1 The selloff is a classic public-market paradox: the operating business is still growing quickly, but the headline numbers and leadership change are triggering early “trust and timing” questions that can hit newly listed stocks especially hard. What’s driving Navan stock today By mid-session, Navan shares were down about 17%–18%, according to multiple market
16 December 2025
Amkor Technology (AMKR) Stock Drops on Dec. 16, 2025: Latest News, Forecasts, and What Investors Are Watching

Amkor Technology (AMKR) Stock Drops on Dec. 16, 2025: Latest News, Forecasts, and What Investors Are Watching

Amkor Technology, Inc. (NASDAQ: AMKR) is having a rough session on Tuesday, Dec. 16, 2025, with shares sliding sharply after a recent run-up. As of the latest available trade timestamp, AMKR was $39.89, down $4.02 (-9.16%) on the day, after trading between $43.88 (intraday high) and $39.89 (intraday low). That kind of move can feel like the floor suddenly became a trapdoor. But for Amkor, today’s volatility lands in the middle of a bigger story: advanced packaging becoming one of the most strategically important choke points in semiconductors—especially as AI and high-performance computing push the industry toward more complex “multi-chip”
16 December 2025
Vertiv (VRT) Stock News Today (Dec. 16, 2025): Why Shares Fell, What Analysts Forecast, and What to Watch Next

Vertiv (VRT) Stock News Today (Dec. 16, 2025): Why Shares Fell, What Analysts Forecast, and What to Watch Next

Vertiv Holdings (often listed as Vertiv Holdings Co. / “Vertiv Holdings, LLC Class A” on market platforms) is ending 2025 with a very familiar investor debate: AI data-center infrastructure demand looks strong, but the stock’s valuation has become a lightning rod. Nasdaq+1 On Tuesday, December 16, 2025, Vertiv shares closed around $158 after another volatile stretch. The stock’s day range was roughly $154.65–$162.47, and the session marked a ~2%+ decline on the day. StockAnalysis+1 That move follows a sharp pullback earlier in the month—including a nearly 10% drop on Dec. 12—as investors reacted to a prominent analyst downgrade, “index inclusion”
16 December 2025
KLA Corporation (KLAC) Stock News Today: Cantor Upgrade, Jefferies $1,500 Target and AI Chip-Equipment Forecasts (Dec. 16, 2025)

KLA Corporation (KLAC) Stock News Today: Cantor Upgrade, Jefferies $1,500 Target and AI Chip-Equipment Forecasts (Dec. 16, 2025)

KLA Corporation stock (NASDAQ: KLAC) is back in the spotlight on December 16, 2025, as a fresh wave of bullish analyst calls collides with new industry forecasts that point to a multi-year upcycle in chipmaking equipment—one that’s increasingly tied to AI-driven demand. KLAC traded around $1,224 in the latest available session check on Tuesday, keeping the stock close to recent highs after a strong move earlier this week following a high-profile Wall Street upgrade (and while investors digest an insider filing that’s drawing attention, even if it’s routine in nature). Below is what’s moving KLA stock today, what analysts are
16 December 2025
Arrowhead Pharmaceuticals (ARWR) Stock Drops on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

Arrowhead Pharmaceuticals (ARWR) Stock Drops on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is seeing a sharp pullback in Tuesday trading (Dec. 16, 2025), with shares recently changing hands around $62—down roughly 9% from the prior close—after hitting an intraday low near $59.76. That drop may look dramatic in isolation, but it’s landing on top of an unusually eventful stretch for the RNA interference (RNAi) biotech: Arrowhead just transitioned into a commercial-stage story after its first FDA approval, picked up an FDA Breakthrough Therapy designation for a follow-on indication, and kicked off a new Alzheimer’s-related clinical program—three ingredients that tend to increase both upside narratives and day-to-day volatility
Compass Inc stock COMP: Latest news, analyst forecasts, and key catalysts on December 16 2025

Compass Inc stock COMP: Latest news, analyst forecasts, and key catalysts on December 16 2025

Compass Inc stock (NYSE: COMP) is back in the spotlight on December 16, 2025, as investors juggle a cocktail of real-estate industry disruption, Big Tech “portal wars,” and a major consolidation bet that could reshape U.S. residential brokerage. By midday Tuesday, COMP was trading around $10.76 after opening at $10.42, with an intraday range roughly $10.28–$10.76 on volume above 2.3 million shares. That price action matters because it comes immediately after a sharp volatility spike tied to a single unnerving question: What happens to real-estate search traffic (and lead economics) if Google decides it wants a bigger slice? Below is
16 December 2025

Stock Market Today

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop